Skip to main content
ConductScienceScienceDex

Xie, Xinmin Simon

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #2,931
Unclaimed recordClaim profile
  • Rising Star
  • Long-Funded
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$2.3M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#2,931
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Xie, Xinmin Simon. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Xie, Xinmin Simon as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS132642-01A1R44Contact PI
    Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
    Afasci, Inc.
    $1.5M
    award amount
  • 1U43AA031391-01U43Contact PI
    Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
    Afasci, Inc.
    $483.9K
    award amount
  • 1R43DA059524-01R43Contact PI
    Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
    Afasci, Inc.
    $319.5K
    award amount

Award organization

Organizations that administered FY2023 awards listing Xie, Xinmin Simon as a PI.

FY2023 award administered by Afasci, Inc. (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Afasci, Inc.
  2. 2006
    $500K Cumulative Funding
  3. 2008
    $1M Cumulative Funding
  4. 2008
    Entered Top 50% Nationally
    Ranked #8454
  5. 2009
    $2M Cumulative Funding
  6. 2014
    $5M Cumulative Funding
  7. 2018
    $10M Cumulative Funding
  8. 2018
    Entered Top 25% Nationally
    Ranked #1551
  9. 2018
    Entered Top 10% Nationally
    Ranked #1551

Explore further

Find collaborators for Xie, Xinmin Simon

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →